HOUSTON, Dec. 8, 2025 /PRNewswire/ — Noble Corporation plc (NYSE: NE, “Noble” or the “Company”) today announced that the Company has signed definitive agreements to sell six jackups, which includes the sale of five rigs to Borr Drilling Limited (NYSE: BORR, “Borr”) for $360 million and a separate transaction for the sale of one rig to… Continue reading NOBLE CORPORATION PLC ANNOUNCES PLANNED DIVESTMENT OF SIX JACKUPS
Tag: Financial Results
MGT Receives Strategic Investment from Ares Management Resulting in First Unicorn in SLED Services Industry
TAMPA, Fla., Dec. 3, 2025 /PRNewswire/ — MGT (the “Company”), a national technology and advisory solutions leader serving state, local, and education (SLED) government clients, announced it has closed a $350 million investment from Ares Credit funds, valuing the Company at $1.25 billion. Ares Management, a leading global alternative investment manager with over $595 billion… Continue reading MGT Receives Strategic Investment from Ares Management Resulting in First Unicorn in SLED Services Industry
Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
GOTHENBURG, Sweden, Dec. 8, 2025 /PRNewswire/ — Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to initiate the company’s Phase IIb trial of its lead… Continue reading Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
GOTHENBURG, Sweden, Dec. 8, 2025 /PRNewswire/ — Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to initiate the company’s Phase IIb trial of its lead… Continue reading Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
Alexandria Real Estate Equities, Inc. Stockholders Can Lead the Securities Class Action – ARE Investors Should Contact Robbins LLP Today
SAN DIEGO, Dec. 8, 2025 /PRNewswire/ — Company: Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a real estate investment trust (REIT) specializing in lifescience real estate with a focus on lab space, research facilities and offices for tenants in the pharmaceutical, biotech, and agricultural technology industries. What is the class period? January 27, 2025 –… Continue reading Alexandria Real Estate Equities, Inc. Stockholders Can Lead the Securities Class Action – ARE Investors Should Contact Robbins LLP Today
StubHub Holdings, Inc. Stockholders can Lead the Securities Class Action – STUB Investors Should Contact Robbins LLP Today
SAN DIEGO, Dec. 8, 2025 /PRNewswire/ — Company: StubHub Holdings, Inc. (NYSE: STUB) operates a global ticketing marketplace for live events where fans can buy tickets from sellers of all types through the Company’s StubHub and viagogo websites and mobile applications. What is the class period? The class includes shareholders who purchased StubHub Holdings, Inc.… Continue reading StubHub Holdings, Inc. Stockholders can Lead the Securities Class Action – STUB Investors Should Contact Robbins LLP Today
AAR extends commercial distribution agreement with Arkwin Industries
WOOD DALE, Ill., Dec. 8, 2025 /PRNewswire/ — AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has signed a multi-year extension of its exclusive, global distribution agreement with Arkwin Industries. The agreement covers Arkwin’s broad line of actuation, valve, and reservoir products on various engine and airframe… Continue reading AAR extends commercial distribution agreement with Arkwin Industries
PepsiCo Announces Priorities to Enhance Shareholder Value and Provides Preliminary 2026 Financial Outlook
Highlights suite of innovation, productivity and affordability initiatives at PepsiCo Foods North America to accelerate growth and improve core1 operating margin performance Expects organic revenue, core constant currency and core earnings per share (EPS) growth to accelerate in fiscal 2026 with strong core operating margin expansion Prioritizes disciplined capital allocation framework, improving free cash flow conversion… Continue reading PepsiCo Announces Priorities to Enhance Shareholder Value and Provides Preliminary 2026 Financial Outlook
John Stankey to Update Shareholders at UBS Global Media & Communications Conference on Dec. 9
DALLAS, Dec. 8, 2025 /PRNewswire/ — Tomorrow, AT&T’s Chairman and Chief Executive Officer will participate in a fireside chat at 8:15 a.m. ET to discuss the Company’s progress on its multi-year growth strategy Key Takeaways: AT&T reiterates all full-year 2025 and multi-year financial guidance and capital return plans provided with its third-quarter 2025 earnings report,… Continue reading John Stankey to Update Shareholders at UBS Global Media & Communications Conference on Dec. 9
Tesla (TSLA) goes all out with new incentives in end-of-year sales push
Tesla is pulling every demand lever available as we head into the final weeks of the year. The automaker has launched a new set of aggressive incentives in the US, including free upgrades on inventory vehicles, 0% APR financing, and $0 down leases. It’s the end of the quarter (and year), and as per usual,… Continue reading Tesla (TSLA) goes all out with new incentives in end-of-year sales push